This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX World Congress Europe
25-26 March 2026
Lisbon Congress Centre, Lisbon, Portugal
25-26 March 2026
Lisbon Congress Centre, Lisbon, Portugal

Navigate Biotech Financing: Secure Capital and Drive Growth


Come to where biotech leaders meet.
Industry insights, trends, best practices & benchmarking.
Meet the right people through one-to-one meetings.

"LSX has evolved into a trusted partnership which helps us connect with innovative and exciting life science companies"
- Senior Director-Business Development Strategic Operations and Intelligence, Lilly

Advancing Innovation

For the last 10 years, we’ve connected biotech leaders with the capital, expertise and networks they need to take their innovations from concept to market.

At the core of our community are the brilliant minds driving progress:

  • Pioneering Entrepreneurs - Founders and CEOs of the most innovative drug discovery and therapeutic startups and SMEs.
  • Visionary Investors - The most active health and life science investors from Europe and the USA.
  • Expert Advisors & Partners -The advisors, service providers and ecosystem enablers helping companies accelerate growth and scale successfully.

3 focused tracks

Early Innovation and Technology Translation

Bridge the gap between breakthrough science and real-world healthcare by exploring the routes that turn cutting-edge discoveries into impactful therapies and technologies.

Capital Markets and Investment Strategies

Gain access to expert insights from some of the industry’s top investors to navigate the shifting biotech financing landscape.

Market Opportunities and Commercialisation

Look no further to find experienced biotech executives and leaders who have been there, done that, and have the battle scars to prove it.

5 Reasons to choose Biotech Leaders


  1. Biotech Leaders is Europe’s most essential gathering for biotech CEOs
    No other event is exclusively framed around the strategic, capital and growth goals of Europe’s biotech leadership ecosystem.
  2. Unmatched access to global capital allocators and pharma
    Hear from senior leaders at pharma companies like GSK, Sanofi, Merck KGaA, Novartis and more - alongside top-tier investors such as Abingworth, Forbion, Sofinnova and SV Health.
  3. Unmatched access to specialist life science investors
    With over 400 investors attending and more than 1,500 participants overall, Biotech Leaders offers the most concentrated gathering of capital allocators in Europe. Fundraising? There’s no better place to be.
  4. Content curated settings for real dialogue
    Alongside the main agenda, Biotech Leaders offers CEO forums, workshops and smaller group meetings, giving you intimate and interactive opportunities to connect with peers and investors that matter most to you.
  5. Partnering system built for efficiency
    The 1-2-1 partnering platform enables you to book targeted meetings in advance, cutting through the noise and maximising your ROI on time spent at the congress.


Snapshot of our 2025 companies